| ［1］Hankey CR.Session 3 (Joint with the British Dietetic Association): Management of obesity: Weight-loss interventions in the treatment of obesity[J]. Proc Nutr Soc, 2010, 69(1):34-38.［2］Maggard MA, Shugarman LR, Suttorp M, et al. Meta ana- lysis: surgical treatment of obesity[J]. Ann Intern Med, 2005, 142(7):547-559. ［3］Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution[J]. J Clin Endocrinol Metab, 2004, 89(6):2608-2615. ［4］Boza C, Gamboa C, Awruch D, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up[J].Surg Obes Relat Dis, 2010, 6(5):470-475.［5］Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity[J]. Am J Manag Care, 2010, 16(7):e174-e187.［6］Ballantyne GH, Wasielewski A, Saunders JK. The surgical treatment of type Ⅱ diabetes mellitus: changes in HOMA Insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB)[J]. Obes Surg, 2009, 19(9):1297-1303.［7］Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study[J]. Arch Surg, 2011, 146(2):149-155.［8］Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial[J]. Arch Surg, 2011, 146(2):143-148.［9］Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery[J]. Clin Endocrinol(Oxf),2008, 69(2):173-179.［10］McLaughlin T, Abbasi F, Lamendola C, et al. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls[J]. J Clin Endocrinol Metab, 2004, 89(4):1630-1635. ［11］Mhlig M, Spranger J, Otto B, et al. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans[J]. J Endocrinol Invest, 2002, 25(11):RC36-RC38. ［12］Gehlert DR. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications[J]. Proc Soc Exp Biol Med, 1998, 218(1):7-22. ［13］Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels[J]. Obesity (Silver Spring), 2006, 14(9):1553-1561. ［14］Scheen AJ, De Flines J, De Roover A, et al. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives[J]. Diabetes Metab, 2009, 35(6 Pt 2):537-543.［15］Rubino F, Gagner M, Gentileschi P. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism[J]. Ann Surg, 2004, 240(2):236-242. ［16］le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass[J]. Ann Surg, 2007, 246(5):780-785. ［17］于健春. 肥胖症的多学科综合治疗模式[J]. 中国医学科学院学报, 2010, 32（1）：1-3. |
Acta Academiae Medicinae Sinica
